Fosun Pharmaceutical bought Concert Pharmaceuticals Concert Pharmaceuticals from 1/19/23

User image

Vladimir Petenev

News editor
press@blackterminal.com

Fosun Pharmaceutical bought Concert Pharmaceuticals for $576 million, or $8 per share.

Concert Pharmaceuticals

Review

Source:

{source} pictogram

ir.concertpharma.com

Vladimir Petenev

News editor

News feed

Fix Price started buyback

9/15/25 FIXR

Ozon Pharmaceuticals has launched the Immunotresan drug on the market

9/15/25 OZPH

T-Bank launches contactless payment service for iPhone

9/15/25 T

Sk Capital received 12.76% of Softline

9/12/25 SOFL

Shareholders of Phosagro approved dividends

9/12/25 PHOR

Promomed and Vinafarm have agreed on strategic cooperation

9/12/25 PRMD

Rostelecom acquired a controlling stake in ASTOR

9/12/25 RTKM

MGKL's revenue in January–August increased 3.3 times

9/12/25 MGKL

M.Video-Eldorado has opened the first brand zone Made in Belarus

9/11/25 MVID

Fesco gained control over part of the assets of PCMTP

9/11/25 FESH